Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Alphabet Replaces Verizon in Dow Jones Industrial Average
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 



